61-year-old male patient with history of HCV and a focal cirrhosis, status post TACE/RFA for HCC. Note the examination is limited by patient motion artifact.ABDOMEN:LIVER, BILIARY TRACT: Cirrhotic liver morphology.RFA defect in the inferior segment six is unchanged with no new arterial enhancement.RFA defect in segment eight of the liver is again noted. There is heterogeneous signal with intrinsic T1 hyperintensity compatible with proteinaceous or blood products, decreased compared to prior exam. Surrounding the RFA defect there is an area of postcontrast enhancement that does not demonstrate washout and correlates with vague T2 hyperintensity, decreased in size compared to prior.No new arterial enhancing lesions.SPLEEN: No significant abnormality noted.PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral renal cysts.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Segment eight ablation defect with interval decrease in intrinsic T1 signal compatible with proteinaceous or hemorrhagic products. Postcontrast enhancement without washout in the adjacent parenchyma appears stable to slightly smaller compared to prior examination and likely represents postinflammatory/perfusional changes as opposed to recurrent cancer.2.Stable segment six ablation defect. No evidence of residual or recurrent tumor.